×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 4: Regulatory and Industry Perspectives in Clinical Development
Session Chair(s)
Jung Yun Chang
Pharmaceutical Standardization Division
Ministry of Food and Drug Safety (MFDS), Korea, Republic of
Session 4.1 : cGMP Inspection cases-common findings
Speaker(s)
Session 4.1 : cGMP Inspection Cases-Common Findings/ Responses in Asia
Charles Ahn
Aegisbeacon, Korea, Republic of
Principal Consultant
Session 4.2 :Differentiation Strategy for the Drugs Preclinical Development Using Orthotropic Animal Models
Sun Jin Kim
Platbio Inc., Korea, Republic of
Chairman/Founder
Session 4.3 :Enhanced Early Clinical Drug Development with Advanced Tools
Hae-Young Ahn, PhD
Ahn Bio, United States
President
Session 4.4 :Clinical Multi-Regional Clinical Trial in Korea
Mee Ryung Ahn, PhD
Ministry of Food and Drug Safety, Korea, Republic of
Director
Have an account?